Introduction {#Sec1}
============

*Delphinium* is a large genus comprising 350 species and distributed in the temperate regions of the Northern Hemisphere, of which 173 are found in mainland China^[@CR1]^. In our continuous phytochemical studies on the pharmacologically interesting plants of the genera *Aconitum* and *Delphinium*, we obtained a series of structurally and chemotaxonomically diverse diterpenoid alkaloids^[@CR2]--[@CR5]^. *Delphinium anthriscifolium* var. *majus* is an herbaceous plant, belonging to the Sect. *Anthriscifolium* of the genus *Delphinium*, and widely distributed in Guizhou, Sichuan, Hubei and Shanxi provinces in China^[@CR6]^. Our earlier chemical investigation of this plant led to the discovery of two new C~18~--diterpenoid alkaloids^[@CR2]^. Further studies on the whole extract of this plant resulted in the isolation and structural determination of three new C~20~--diterpenoid alkaloids, anthriscifolsines A--C (**1**--**3**), six new C~19~--diterpenoid alkaloids, anthriscifolrines A--F (**4**--**9**) (Fig. [1](#Fig1){ref-type="fig"}), and five know alkaloids nudicaulamine (**10**)^[@CR7]^, anthriscifolmine C (**11**)^[@CR8]^, anthriscifolmine D (**12**)^[@CR9]^, anthriscifolmine I (**13**)^[@CR10]^, and hetisine 13--O--acetate (**14**)^[@CR11]^. Anthriscifolsine A represents a new type of C~20~--diterpenoid alkaloid, featuring a seco C--ring through an unprecedented C11--C12 bond cleavage of hetisine-type skeleton, whose stereostructure has been unambiguous established by an X--ray crystallographic analysis. Cytotoxicity of diterpenoid alkaloids against MCF--7, HepG2 and H460 cancer cell lines was also evaluated by the MTT method. Herein, we report the isolation, structural elucidation and bioactivity of these diterpenoid alkaloids.Figure 1Structures of compounds **1**--**14**.

Results {#Sec2}
=======

Anthriscifolsine A (**1**) was obtained as needles via crystallization from MeOH. Its molecular formula, C~29~H~31~NO~7~, was deduced from the HR--ESI--MS (*m/z* 506.2182 \[M + H\]^+^, calcd for C~29~H~32~NO~7~, 506.2179) and ^13^C NMR spectroscopic data. The ^1^H NMR data (Table [1](#Tab1){ref-type="table"}) displayed characteristic resonances of two methyl \[*δ* ~*H*~ 1.10, 1.97 (each 3 H, s)\], an acetyl \[*δ* ~*H*~ 2.29 (3 H, s)\], a benzoyl \[*δ* ~*H*~ 7.32 (2 H, t, *J* = 7.8 Hz), 7.51 (1 H, t, *J* = 7.8 Hz), 7.89 (2 H, d, *J* = 7.8 Hz)\], and an aldehyde \[*δ* ~*H*~ 9.84 (1 H, br.s)\] groups. The ^13^C NMR and DEPT spectra of **1** exhibited the presence of two methyls (*δ* ~*C*~ 18.8, 24.6), three methylenes (*δ* ~*C*~ 33.2, 33.5, 36.3), eight sp^3^ methines (*δ* ~*C*~ 54.9, 58.5, 59.1, 61.1, 63.9, 67.3, 74.3, 88.4), and three sp^3^quaternary carbons (*δ* ~*C*~ 44.4, 47.1, 47.6), one trisubstituted double bond (*δ* ~*C*~ 124.6, 158.5), one aldehyde (*δ* ~*C*~ 201.0), one keto carbonyl (*δ* ~*C*~ 196.1). In addition, an acetyl group \[*δ* ~*C*~ 21.6 (q), 169.8 (s)\], a benzoyl group \[*δ* ~*C*~ 129.8 (s), 129.7 × 2 (d), 128.4 × 2 (d), 133.2 (d), 165.5 (s)\] were presented in the structure according to the NMR spectra. These characteristic spectroscopic data suggested that **1** was a typical skeleton of C~20~--diterpenoid alkaloid diester^[@CR9]^. The proton and corresponding carbon resonances in the 2D NMR spectra of **1** were assigned by the HMQC experiment. The existence of three oxygenated carbons deduced from its ^13^C NMR spectrum suggests that **1** has a hydroxyl group, in addition to two ester groups. The absence of a typical C--19 methylene signals in its NMR spectra suggested that a hydroxyl group might be located at C--19, which was confirmed by the HMBC correlations (Fig. [2](#Fig2){ref-type="fig"}) from H--3, H~3~--18 and H--5 to C--19^[@CR9]^. The acetoxy group could be assigned to C--2 and the benzoyl group at C--3 respectively, on the basis of the HMBC correlations from H--2 (*δ* ~*H*~ 5.59, m) to the carbonyl carbon of the acetyl group at *δ* ~*C*~ 169.8 and H--3 (*δ* ~*H*~ 5.18, d, *J* = 4.8 Hz) to the carbonyl carbon at *δ* ~*C*~ 165.5 of the benzoyl group. Compound **1** has the same macular formula and similar NMR spectraoscopic data with those of anthriscifolmine C (**11**)^[@CR9]^, which also possesses an acetyl group at C--2 and a benzoyl group at C--3. However, compound **1** differs from anthriscifolmine C (**11**) mainly at C--11 where an aldehyde group and a trisubstituted double bond between C--12 and C--16 were deduced. Two methys group were shown to be attached at C--4 and C--16 according to the HMBC correlations from H~3~--18 to C--3, C--4, C--5 and C--19, and H~3~--17 to C--12, C--15 and C--16. The substitution pattern and the assigned planar structure of **1** were confirmed by complete ^1^H−^1^H COSY and HMBC spectroscopic analysis.Table 1NMR Spectroscopic Data^a^ for Compounds **1--3** (600 MHz for ^1^H, 150 MHz for ^13^C, CDCl~3~, *δ* ppm).*No*.123*δ* ~H~*δ* ~C~*δ* ~H~*δ* ~C~*δ* ~H~*δ* ~C~1α 1.98 d (13.8) β 2.31 dd (4.8, 15.6)33.2 tβ 1.99 dd (4.2, 15.0) α 2.98 dd (2.4, 15.0)31.0 tβ 1.56 dd (4.2, 15.6) α 2.50 dd (1.8, 15.6)28.8 t25.59 m67.3 d5.35 m68.7 d5.29 m71.2 d35.18 d (4.8)74.3 d4.93 d (4.8)74.0 d3.67 d (5.4)74.7 d4---47.6 s---42.6 s---43.0 s51.95 br.s54.9 d1.78 br.s61.6 d1.68 br.s61.6 d63.77 br.s61.1 d3.13 br.s62.7 d---97.0 s7α 1.88 br.d (13.8) β 2.28 br.d (13.8)33.5 tβ 1.39 dd (1.8,13.8) α 1.87dd (3.0,10.2)31.8 tβ 1.81 d (12.6) α 1.85 d (13.2)41.0 t8---44.4 s---44.3 s---46.7 s92.43 br.s59.1 d---80.2 s2.43 m47.1 d10---47.1 s---46.3 s---48.1 s119.84 br.s201.0 d4.10 br.s80.3 d4.13 br.d (9.6)70.2 d125.93 s124.6 d52.7 d2.17 m42.9 d13---196.1 s4.26 d (8.4)76.0 dβ 1.39 m α 2.06 dd (4.2, 9.6)21.6 t142.56 br.s58.5 d1.99 d (9.6)53.3 d1.72m48.0 d15β2.47 d (19.8) α 2.76 d (19.8)36.3 tα 2.99 dd (2.4, 16.2) β 2.00 overlapped31.2 t5.54 br.s70.6 d16---158.5s---144.3s---148.5s171.97 s24.6 q4.90 br.s 4.72 br.s108.7 t4.87 d (1.8) 4.98 d (1.8)111.2 t181.10s18.8 q1.04s25.8 q1.54s27.1 q195.20s88.4 dα 2.50 d (12.6) β 3.37 d (12.6)59.9 tα 3.00 d (12.0) β 3.16 d (12.0)57.8 t204.36 br.s63.9 d3.71 br.s68.9 d3.72 br.s66.8 dAcO--2AcO--2---169.8 s---170.2 s---177.3 s2.29 s21.6 q2.02 s20.9 q2.44 m41.9 dBzO--3AcO--31.73 m26.8 t1′---129.8s---170.6 s0.91 t (7.2)11.9 q2′, 6′7.89 d (7.8)129.7 d2.09 s21.5 q1.20 d (7.2)16.8 q3′, 5′7.32 t (7.8)128.4 dMbO--154′7.51 t (7.8)133.2 d---176.8 sC = O---165.5 s2.40 m41.6 d1.50 m26.7 t0.93 t (7.2)11.8 q1.16 d (7.2)17.0 q^a^Data are based on DEPT, HMQC, and HMBC experiments. Figure 2Key HMBC and ^1^H--^1^H COSY interactions of compounds **1**--**3**.

The NOESY correlations of H--1*β* and H--3, H--3 and H--5, H--1*α* and H--11, H--1*α* and H--20, H--19 and H--20, proved that H--3 was *β*--oriented, H--11 and H--19 were in α--orientation (Fig. [3](#Fig3){ref-type="fig"}). The NOESY correlations indicated that H--2 was in an equatorial position, which indicated a *β*--orientation. Moreover, an X--ray diffraction experiment with a suitable crystal was conducted and the absolute configuration of **1** was established as H--2*β*, H--3*β*, H--11*α*, H--19*α* (19--s) (Fig. [4](#Fig4){ref-type="fig"}), consistent with the absolute configuration determined by NOESY correlations. Thus, the structure of **1** was assigned as shown in Fig. [1](#Fig1){ref-type="fig"}.Figure 3Key NOESY correlations of compounds **1--3**. Figure 4ORTEP projection of compound **1** (crystallographic numbering).

A possible biogenetic pathway of anthriscifolsine A (**1**) was proposed as shown in Fig. [5](#Fig5){ref-type="fig"}. Aldehyde **A** could be generated from the known alkaloid anthriscifolmine C (**11**) through a critical retro--aldol process involving the cleavage of C11--C12 bond. The latter has been also isolated from this plant, which was obtained as needles crystal (MeOH), and the structure of which was unambiguously confirmed by an X--ray crystallographic analysis (Fig. [6](#Fig6){ref-type="fig"}). The unstable intermediate **A** then underwent proton shift and epimerization of the C9 stereochemistry, thus leading to anthriscifolsine A (**1**). Finally, the artificial possibility of anthriscifolsine A (**1**) had been explicitly excluded used UPLC--HRESI--MS method and the detailed experiments were added the Supporting Information.Figure 5Postulated biogenetic pathway of anthriscifolsine A (**1**). Figure 6ORTEP projection of compound **11** (crystallographic numbering).

Anthriscifolsine B (**2**) was obtained as a white amorphous powder. Its molecular formula C~24~H~31~NO~7~ was derived from a pseudomolecular ion at *m/z* 446.2196 \[M + H\]^+^ in its HR--ESI--MS. It exhibited characteristic NMR features of a hetisine--type C~20~--diterpenoid alkaloid bearing groups including two acetyl groups, and an exocyclic double bond (Table [1](#Tab1){ref-type="table"})^[@CR12]^. Two acetyl groups can be installed at C--2 and C--3, respectively, on the basis of the HMBC correlations from H--2 (*δ* ~*H*~ 5.35, m) to the carbonyl carbon of one acetyl group at *δ* ~*C*~ 170.2 and H--3 (*δ* ~*H*~ 4.93, d, *J* = 4.8 Hz) to the carbonyl carbon of another acetyl group at *δ* ~*C*~ 170.6. Along with the abovementioned signals, its ^13^C NMR spectrum displayed five oxygenated carbon signals, suggesting that this compound possessed three additional hydroxyl groups in addition to two ester groups. Two hydroxyl groups were assigned at C--11 and C--13 based on the HMBC correlations from H--11 to C--10, C--13 and C --16, and H--13 to C --11, and COSY correlations of H--11/H--12/H--13/H--14. The observation of HMBC crosspeak between C--9 (*δ* ~*C*~ 80.2) and H--1 (*δ* ~*H*~ 1.99), H--7(*δ* ~*H*~ 1.39), H--12 (*δ* ~*H*~ 2.51), and H--20 (*δ* ~*H*~ 3.71), facilitated the location of the third hydroxyl group at C--9.

The relative configuration of **2** was deduced from the vicinal coupling constants and a NOESY experiment (Fig. [3](#Fig3){ref-type="fig"}). The coupling constant (*J* = 4.8 Hz) of H--2 with H--3, indicated that H--2 was in an equatorial position, which indicated a β--orientation^[@CR9]^. The large coupling constant of H--13 (*J* = 8.4 Hz) with H--14α revealed that the dihedral angle between these two H--atoms was *ca*. 0 °C, which implied that H--13 was in an *α*--orientation^[@CR9]^. In the NOESY spectrum of **2**, the cross--peak between H--1*β* and H--3, H--3 and H--5, H--1*α* and H--11, H--1*α* and H--20, proved that H--3 was *β*--oriented and H--11was in *α*--orientation. Therefore, the structure of anthriscifolsine B was determined as shown in Fig. [1](#Fig1){ref-type="fig"}, and the full assignment of its spectroscopic data was achieved based on the 1D-- and 2D NMR analysis (Table [1](#Tab1){ref-type="table"}, Fig. [2](#Fig2){ref-type="fig"}).

Anthriscifolsine C (**3**) was isolated as a white amorphous powder and its molecular formula was deduced to be C~30~H~43~NO~7~ by HR--ESI--MS at *m/z* 530.3118 \[M + H\]^+^. The ^1^H NMR and ^13^C NMR data (Table [1](#Tab1){ref-type="table"}) of **3** indicated the presence of the signals of two 2--methylbutanoyloxy groups (MbO) at \[(*δ* ~H~ 2.44 (1 H, m), 1.73 (2 H, m), 0.91(3 H, t, *J* = 7.2 Hz), 1.20 (3 H, d, *J* = 7.2 Hz) and *δ* ~C~ 177.3 (s), 41.9 (d), 26.8 (t), 11.9 (q), 16.8 (q)\] and \[(*δ* ~H~ 2.40 (1 H, m), 1.50 (2 H, m), 0.93 (3 H, t, *J* = 7.2 Hz), 1.16 (3 H, d, *J* = 7.2 Hz) and *δ* ~C~ 176.8 (s), 41.6 (d), 26.7 (t), 11.8 (q), 17.0 (q)\]^[@CR2]^. The remaining 20 carbons were assigned based on 1D-- and 2D--NMR data and exhibited characteristic NMR features of a hetisine--type C~20~--diterpenoid alkaloid^[@CR12]^ bearing five methylenes, nine methines (four oxygenated) and five quaternary carbons (one ester carbonyl), in addition to one methyl group that was attached to a quaternary carbon (Table [1](#Tab1){ref-type="table"}). The presence of an exocyclic double bond was evidenced by singals in the ^1^H NMR spectrum (*δ* ~H~ 4.87, d, *J* = 1.8 Hz, 4.98, d, *J* = 1.8 Hz) and ^13^C NMR spectrum (*δ* ~C~ 111.2 and 148.5). The locations of two 2--methylbutanoyloxy groups at C--2 and C--15 were determined by the correlations in the HMBC experiment (Fig. [2](#Fig2){ref-type="fig"}). The ^13^C NMR spectrum showed a singlet at *δ* ~C~ 97.0, indicative of a carbinolamine carbon (C--6). Besides the two ester groups and the carbinolamine carbon, there were two OH groups in the molecule, which were placed at C--3 and C--11, respectively, according to the HMBC displayed in Fig. [2](#Fig2){ref-type="fig"}. The coupling constant (*J* = 5.4 Hz) of H--2 with H--3 indicated that H--2 was in an equatorial position, namely, a *β*--orientation.

The key NOE correlations of H--1*β* with H--3, H--3 with H--5, H--1*α* and H--11, H--1*α* with H--20, H--15 with H--7*α*, H--15 with H--14, indicated the orientation of H--3*β*, H--11*α* and H--15*α*. On the basis of the aforementioned evidence, the structure of **3** was determined, and the trivial name anthriscifolsine C was assigned to this compound.

HR--ESI--MS of anthriscifolrine A (**4**) gave a molecular ion at *m/z* 448.2757 \[M + H\]^+^ (calcd. for C~25~H~38~NO~6~, 448.2699), corresponding to the molecular formula C~25~H~37~NO~6~. Its NMR data indicated seven methylene (one oxymethylene), seven (two oxymethines), and five quaternary carbons (a carbonyl and two oxygen--bearing), in addition to a methylenedioxy group, an *N*--ethyl, and three methoxy substituents, suggesting that **4** was a typical lycoctonine C~19~--diterpenoid alkaloid^[@CR13]^. The 2D NMR and NOESY experiments confirmed the NMR data and configuration assignments of **4**. In particular, HMBC correlations of C--14 with H--9, H--12, H--13, and H--16 confirmed the 14--keto group, while HMBC correlations of the protons of the methylenedioxy with C--7 and C--8, OCH~3~--1 with C--1, OCH~3~--16 with C--16, OCH~3~--18 with C--18, confirmed the locations of the methylenedioxy and three methoxy groups. The *α*--oriented 1--OCH~3~ and *β*--oriented 16--OCH~3~ in compound **4** were deduced from the vicinal coupling constants (Table [2](#Tab2){ref-type="table"})and a NOESY experiment (Fig. [7](#Fig7){ref-type="fig"}). The structure of anthriscifolrine A was thus established.Table 2NMR Spectroscopic Data^a^ for Compounds **4**--**6** (600 MHz for ^1^H, 150 MHz for ^13^C, CDCl~3,~ *δ* ppm).*No*.456*δ* ~H~*δ* ~C~*δ* ~H~*δ* ~C~*δ* ~H~*δ* ~C~13.85 t (5.4)84.3 d3.57 t (8.4)78.1 d3.63 m77.2 d22.27 m26.1 t2.40 m26.6 t2.18 m26.0 t31.73 m32.4 t*α* 1.40 m *β* 1.73 m32.2 t*α* 1.40 m *β* 1.77 m31.7 t4---38.6 s---38.1 s---38.3 s52.02 m46.0 d1.80 m39.2 d1.83 m45.9 d61.40 m31.7 t*α* 2.11 m *β* 1.50 m32.8 d5.52 s78.3 d7---91.6 s---90.6 s---93.2 s8---88.0 s---82.7 s---83.2 s92.44 m52.1 d2.42 d (4.8)53.4 d3.37 m52.3 d101.55 d (7.8)44.2 d---79.8 s---79.8 s11---51.2 s---55.8 s---55.0 s12*α* 2.01 m *β* 2.23 m24.9 t*α* 1.81 m *β* 2.85 m38.5 t*α* 1.79 m *β* 2.50 m33.0 t132.66 m45.6 d2.76 m36.2 d2.60 m36.6 d14---213.7s5.26 t (5.4)74.7 d4.64 m72.9 d15*α* 2.09 m *β* 1.42 m31.5 t*α* 2.55 dd (9.6,16.2) *β* 1.74 m34.4 t*α* 2.45 m37.4 t163.15 dd (6.6, 10.8)84.8 d3.20 q (5.4, 9.6)81.2 d3.47 t (8.8)81.3 d173.59 brs63.5 d2.98 brs65.1 d3.34 m64.9 d183.01 d (9.0) 3.08 d (9.0)78.9 t3.00 d (9.0) 3.13 d (9.0)79.1 t3.05 d (9.2) 3.18 d (9.2)78.3 t192.45 m 2.63 m52.7 t2.45 m 2.65 d (11.4)52.6 t2.42 m 2.78 m53.4 t212.46 m 2.85 dd (7.2, 12.6)51.0 t2.70 dd(7.2, 12.6) 2.81 dd(7.2, 12.6)50.7 t2.83 m50.6 t221.09 t (7.2)14.3 q1.07 t (7.2)14.1 q1.07 t (7.2)14.1 q1--OCH~3~3.29 s56.1 q3.27 s55.8 q3.25 s55.7 q16--OCH~3~3.31 s56.2 q3.28 s56.3 q3.26 s56.5 q18--OCH~3~3.34 s59.6 q3.29 s59.63.35 s59.5 qO--CH~2~--O4.95 s, 5.04 s94.1 t4.95 s, 5.01 s93.8 t4.96 s, 4.98 s94.3 t14-- OAc---171.9s---170.2 s2.07 s21.5 q2.10 s21.8 q^a^Data are based on DEPT, HMQC, and HMBC experiments. Figure 7Key ^1^H--^1^HCOSY, HMBC and NOSEY correlations of **4**.

The molecular formula of anthriscifolrine B (**5**) was determined as C~27~H~41~NO~8~ by HR--ESI--MS at *m/z* 508.2952 \[M + H\]^+^ (calcd. for C~27~H~42~NO~8~, 508.2910). The NMR spectroscopic data of **5** were similar to those of **4**, suggesting **5** was also a lycoctonine C~19~--diterpenoid alkaloid with an acetyl group, an *N*--ethyl group, three methoxyl groups, and a methylenedioxy group^[@CR13]^. In the HMBC spectrum of **5**, critical correlations for the protons of the methylenedioxy/C--7 and C--8, OCH~3~--1/C--1, OCH~3~--16/C--16, OCH~3~--18/C--18, H--14/OAc, suggested the location of three methoxyl groups at C--1, C--16 and C--18, the acetyl group at C--14, and the methylenedioxy group at C--7 and C--8. Its ^13^C NMR spectrum displayed seven oxygenated carbon signals, suggesting that it possessed an additional hydroxyl group in addition to three methoxy groups, an ester group, and a methylenedioxy group. The additional hydroxyl group in **5** was assigned to C--10 on the basis of the correlations of C--10 (*δ*c 79.8) with H--1 (*δ* ~H~ 3.57), H--9 (*δ* ~H~ 2.42), H--13 (*δ* ~H~ 2.76) and H--17 (*δ* ~H~ 2.98) in the HMBC spectrum. The configurations of 1*α*--OCH~3~, 16*β*--OCH~3~, 14*α*--OAc and constant18*β*--OCH~3~ were deduced by the vicinal coupling constants (Table [2](#Tab2){ref-type="table"}) and a NOESY experiment. Thus, the structure of anthriscifolrine B was confirmed by NMR experiments.

The molecular formula of anthriscifolrine C (**6**) was determined as C~27~H~41~NO~9~ (HR--ESI--MS). The ^1^H and ^13^C NMR data (Table [2](#Tab2){ref-type="table"}) of **6** showed close structural similarity to compound **5**, and the distinction between the two sets of spectra was demonstrated by the presence of an additional hydroxyl group signal in **6**, which was validated by the additional 16 mass units in mass spectrometry. The proton signal of H--6 at \[*δ* ~*H*~ 2.11 (1 H, m), 1.50 (1 H, m) and *δ* ~*C*~ 32.8 (t)\] in compound **5** was shifted downfield to \[*δ* ~*H*~ 5.52 (1 H, s), *δ* ~*C*~78.3(d)\] in compound **6**, suggesting that the hydroxyl group in **6** might be located at C--6, which was further confirmed by the HMBC correlations. The hydroxyl group at C--6 was determined to have a *β*--orientation based on the multiplicity of H--6 (singlet) in the ^1^H NMR spectrum^[@CR2]^. Thus, the structure of anthriscifolrine C was determined as shown in Fig. [1](#Fig1){ref-type="fig"}.

Anthriscifolrine D (**7**), a white amorphous powder, C~27~H~39~NO~9~ (HR--ESI--MS), was also a lycoctonine--type C~19~--diterpenoid alkaloid. By comparison of the NMR data of **7** with those of **4**, the main difference was the presence of a acetyl and a hydroxyl groups. In the HMBC experiment, long--range correlations were observed from H--6 (5.54) to the carbonyl carbon of the acetyl group at *δ* ~*C*~ 170.2, and H--1 (*δ* ~H~ 3.91), H--9 (*δ* ~H~ 3.49), H--13 (*δ* ~H~ 2.82) and H--17 (*δ* ~H~ 3.71) to C--10 (*δ*c 79.8) supported the hydroxyl group at C--10. The structure of anthriscifolrine D (Fig. [1](#Fig1){ref-type="fig"}) was confirmed by the analysis of its 2D NMR data.

The molecular formula of anthriscifolrine E (**8**) was deduced to be C~26~H~39~NO~8~ from its HR--ESI--MS at *m/z* 494.2752 \[M + H\]^+^. From its NMR data (Table [3](#Tab3){ref-type="table"}), an *N*--ethyl group, two methoxy groups, an acetoxy group, and a methylenedioxy group could be easily recognized. Compound **8** shared highly similar ^1^H-- and ^13^C--NMR spectral patterns with those of **5**. The only difference is that the absence of a methoxy group and the presence of a hydroxy group at C--18 in **8**, which was further supported by comparison of the NMR data: the C--18 signal in **8** appeared at *δ* ~*C*~ 68.3 instead of at *δ* ~*C*~ 79.1 in **5**. The structure of anthriscifolrine E was unquestionably confirmed by extensive analyses of its 1D and 2D NMR spectra.Table 3NMR Spectroscopic Data^a^ for Compounds **7**--**9** (600 MHz for ^1^H, 150 MHz for ^13^C, CDCl~3,~ *δ* ppm).*No*.789*δ* ~H~*δ* ~C~*δ* ~H~*δ* ~C~*δ* ~H~*δ* ~C~13.91 t (5.4)83.8 d3.60 t (7.2)78.0 d3.55 t (5.4)78.2 d22.15 m25.6 t*α* 2.12 m *β* 2.35 m26.6 t2.12 m 2.35 m26.7 t31.40 m 1.70 m31.5 t1.70 m31.6 t1.49 m32.1 t4---38.5 s---38.4 s---38.4 s51.86 brs45.9 d1.75 m38.4 d2.02 m38.6 d65.54 s77.9 d1.45 m 2.12 m32.6 t1.45 m 2.15 m32.7 t7---92.7 s---90.6 s---90.3 s8---87.0 s---79.9 s---80.2 s93.49 s58.5 d2.45 d (4.8)53.2 d2.31 m54.0 d10---79.8 s---82.7 s---83.4 s11---55.0 s---56.3 s---56.5 s121.69 m 2.38 dd (6.0,16.8)31.1 t*α* 1.90 d (7.2) *β* 2.85 m38.6 t*α* 1.70 m *β* 3.01 d (15.6)39.4 t132.82 m45.3 d2.75 m36.4 d2.55 m38.0 d14213.2 s5.26 t (5.4)74.7 d4.12 t (4.8)81.7 s151.96 dd (7.2,15.6) 2.74 m36.2 t*α* 2.55 dd (9.6, 16.2) *β* 1.74 m34.4 t*α* 2.50 m *β* 1.89m34.1 t163.77 dd (7.2, 10.2)76.9 d3.20 dd (4.8, 9. 0)81.2 d3.17 dd (4.8, 9.0)81.7 d173.71 d (2.4)65.3 d2.99 brs62.2 d2.97 brs61.9 d183.04 d (9.6) 3.14 d (9.6)78.1 t3.25 m 3.40 d (11.4)68.3 t3.31 m 3.43 m68.5 t192.49 m 2.75 m53.3 t2.38 d (11.4) 2.61 d (11.4)52.4 t2.41 d (11.4) 2.62 d (11.4)52.4 t212.73 m 2.87 m50.7 t2.72 m 2.82 m50.8 t2.70 m 2.82 m50.7 t221.09 t (7.2)14.1 q1.08 t (7.2)14.1 q1.08 t (7.2)14.3 q1--OCH~3~3.31 s55.8 s3.27 s55.8 q3.28 s55.8 q14--OCH~3~------------3.45 s58.0 q16--OCH~3~3.34 s56.3 q3.28 s56.3 q3.33 s56.5 q18--OCH~3~3.24 s59.5 q------------O--CH~2~--O4.95 s, 4.96 s94.8 t4.94 s, 5.01 s93.8 t4.94 s, 5.02 s93.9 t6--OAc170.2 s------------2.08 s21.7 q------------14--OAc---------172.1 s------------2.08 s21.5 q------^a^Data are based on DEPT, HMQC, and HMBC experiments.

Comparison of spectroscopic data of anthriscifolrine F (**9**) and E (**8**) indicated that an acetyl group in **8** was substituted by a methoxy group in **9**. According to 2D NMR analysis, especially the HMBC correlation of OCH~3~/C--14, the OCH~3~ group was attributed to C--14 in **9**. The corresponding structure of **9** was confirmed by DEPT, HMQC, ^1^H--^1^H COSY, and HMBC experiments. Thus, anthriscifolrine F was assigned as shown in Fig. [1](#Fig1){ref-type="fig"}.

To evaluate the biological activities of these compounds isolated from the whole plant of *D.anthriscifolium* var. *majus*, compounds **3**--**6** were tested for their *in vitro* cytotoxicity against the MCF--7, HepG2 and H460 cancer cell lines. Unfortunately, all of the compounds were inactive (IC~50~ \> 50 *μ*M, *n* = 3).

Discussion {#Sec3}
==========

Investigation on the whole plant of *Delphinium anthriscifolium* var. *majus* resulted in the isolation of nine new diterpenoid alkaloids named anthriscifolsines A--C (**1**--**3**) and anthriscifolrines A--F (**4**--**9**), together with five known alkaloids (**10**--**14**). Notably, anthriscifolsine A (**1**) is the first naturally occurring C~20~--diterpenoid alkaloid with a unique seco C--ring generated by an unprecedented C11--C12 bond cleavage, and its possible biogenetic pathway was proposed. Since the Sect. *Anthriscifolium* only comprises three species (*D. anthriscifolium*, *D. anthriscifolium* var. *majus*, and *D. anthriscifolium* var. *savatieri*), the present research would be particularly valuable in understanding their chemotaxonomical significance. The identification of various C~19~-- and C~20~--diterpenoid alkaloids from *D. anthriscifolium* var. *majus* revealed its transitional position among the *Delphinium* plants.

Materials and Methods {#Sec4}
=====================

General Experimental Procedures {#Sec5}
-------------------------------

Optical rotations were measured using a Perkin--Elmer 341 polarimeter. The IR spectra were obtained using a Thermo Fisher Nicolet 6700 spectrometer and KBr pellets in cm^−1^. The HR--ESI--MS data were measured using a Q--TOF micro mass spectrometer (Waters). The 1D and 2D NMR spectra were recorded using a Bruker AV 600 with TMS. Silica gel (Qingdao Haiyang Chemical Co., Ltd., 200--300 mesh) was used for column chromatography (CC). The TLC plates were precoated with silica gel GF~254~ (Qingdao Haiyang Chemical Co., Ltd., China), and it was visualized under a UV lamp at 254 nm or by spraying with Dragendorff's reagent or iodine.

Plant Material {#Sec6}
--------------

The whole herbs of *D. anthriscifolium* var. *majus* were collected in Longshanwa, Zhuxi county, Hubei province of China, in April 2015, and were identified (voucher specimen: L H. Shan & J X. Wang 801) by Prof. Qing--Er Yang of the Institute of Botany, Chinese Academy of Sciences.

Extraction and Isolation {#Sec7}
------------------------

Dried and powdered whole herbs of *D. anthriscifolium* (21.5 kg) were extracted with 95% EtOH four times at room temperature, with each soaking process lasting a week. After removal of the solvent by evaporation, the ethanol extract (2000 g) was recovered. The extract was suspended in H~2~O (3 L) and adjusted to pH 2 with HCl, and successively extracted with petroleum ether (4 × 1 L) and ethyl acetate (4 × 1 L). The pH of aqueous layer was adjusted to 10 with aqueous ammonia solution and extracted with CH~2~Cl~2~ (4 × 1 L). The CH~2~Cl~2~ extracts were concentrated to produce the crude alkaloid extract (28.5 g). Column chromatography of the crude alkaloid extract over silica gel, using a CH~2~Cl~2~:MeOH (80:1, v/v) mixture with increasing polarity afforded fractions A--D based on TLC analysis.

Fraction A (10.7 g) was submitted to silica gel CC eluting with petroleum ether/Me~2~CO/Et~2~N (50: 1: 0.1 to 20:1:0.1, v/v/v) to yield compounds **4** (14 mg), **10** (20 mg) respectively.

Fraction B (7.2 g) was submitted to silica gel CC eluting with petroleum ether/Me~2~CO/Et~2~N (15: 1: 0.1 to 6:1:0.1, v/v/v) to yield compounds **5** (20 mg), **6** (43 mg) and **12** (8 mg).

Fraction C (5.6 g) was subjected to silica gel CC, petroleum ether/Me~2~CO/Et~2~N (15: 1: 0.1 to 6:1:0.1, v/v/v) to yield compounds **1** (16 mg), **11** (14 mg), **7** (10 mg) and **3** (4.9 mg).

Fraction D (5.0 g) was subjected to silica gel CC, eluted with CH~2~Cl~2~:MeOH (30:1 to 10:1, v/v) to get four fractions (D~1~--D~4~), fraction D~1~ was subjected to Sephadex LH--20 column chromatography (MeOH) to yield compounds **13** (14 mg) and **14** (8 mg), fraction D~2~ was further purified using an RP--18 silica gel column with MeOH: H~2~O (10:90 to 30:70, v/v) as the mobile phase to yield compounds **2** (7.6 mg), **8** (20 mg), and **9** (11 mg).

Spectroscopic data of 1--9 {#Sec8}
--------------------------

**Anthriscifolsine** A (**1)**: needle crystal (MeOH); $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$${[{\rm{\alpha }}]}_{{\rm{D}}}^{20}$$\end{document}$ + 11.1 (*c* 0.38, CHCl~3~); IR (KBr) *v* ~max~: 3465, 3070, 2928, 2880, 2854, 2747, 1744, 1716, 1667, 1630, 1450, 1381, 1340, 1276, 1233, 1121, 1062, 1038, 997, 965, 942, 909, 752, 715; ^1^H and ^13^C NMR data see Table [1](#Tab1){ref-type="table"}; HR--ESI--MS at *m/z* 506.2182 \[M + H\]^+^ (calcd. for C~29~H~32~NO~7~, 506.2179).

**Anthriscifolsine** B (**2)**: white, amorphous powder; $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
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                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$${[{\rm{\alpha }}]}_{{\rm{D}}}^{20}$$\end{document}$ + 1.1 (*c* 0.38, CHCl~3~); IR (KBr) *v* ~max~: 3408, 2925, 2853, 1741, 1655, 1371, 1251, 1063, 1042, 985, 769, 719; ^1^H and ^13^C NMR data see Table [1](#Tab1){ref-type="table"}; HR--ESI--MS at *m/z* 446.2196 \[M + H\]^+^ (calcd. for C~24~H~32~NO~7~, 446.2179).

**Anthriscifolsine** C (**3)**: white, amorphous powder; $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$${[{\rm{\alpha }}]}_{{\rm{D}}}^{20}$$\end{document}$ −9.8 (*c* 0.25, CHCl~3~); IR (KBr) *v* ~max~: 3443, 2967, 2935, 2878, 1727, 1656, 1462, 1383, 1265, 1237, 1187, 1152, 1077, 1135, 1009, 997, 906, 754, 715; ^1^H and ^13^C NMR data see Table [1](#Tab1){ref-type="table"}; HR--ESI--MS at *m/z* 530.3118 \[M + H\]^+^ (calcd. for C~30~H~44~NO~7~, 530.3118).

**Anthriscifolrine** A (**4)**: white, amorphous powder; $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
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                \usepackage{amsbsy}
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                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$${[{\rm{\alpha }}]}_{{\rm{D}}}^{20}$$\end{document}$ −4.2 (*c* 0.50, CHCl~3~); IR (KBr) *v* ~max~: 3423, 2953, 2925, 2854, 1752, 1648, 1463, 1377, 1094, 954, 734, 721; ^1^H and ^13^C NMR data see Table [2](#Tab2){ref-type="table"}; HR--ESI--MS at *m/z* 448.2757 \[M + H\]^+^ (calcd. for C~25~H~38~NO~6~, 448.2699).

**Anthriscifolrine** B (**5)**: white, amorphous powder; $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
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                \usepackage{mathrsfs}
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                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$${[{\rm{\alpha }}]}_{{\rm{D}}}^{20}$$\end{document}$ −26.7 (*c* 0.30, CHCl~3~); IR (KBr) *v* ~max~: 3472, 2958, 2923, 2875, 2823, 2755, 1740, 1718, 1456, 1369, 1248, 1206, 1092, 1075, 1054, 961, 934, 755, 730; ^1^H and ^13^C NMR data see Table [2](#Tab2){ref-type="table"}; HR--ESI--MS at *m/z* 508.2952 \[M + H\]^+^ (calcd. for C~27~H~42~NO~8~, 508.2910).

**Anthriscifolrine** C (**6)**: white, amorphous powder; $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
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                \begin{document}$${[{\rm{\alpha }}]}_{{\rm{D}}}^{20}$$\end{document}$ −2.3 (*c* 0.70, CHCl~3~); IR (KBr) *v* ~max~: 3438, 2972, 2927, 2875, 2829, 2750, 1738, 1666, 1453, 1387, 1368, 1246, 1232, 1090, 1045, 961, 918, 756, 715; ^1^H and ^13^C NMR data see Table [2](#Tab2){ref-type="table"}; HR--ESI--MS at *m/z* 524.2867 \[M + H\]^+^ (calcd. for C~27~H~42~NO~9~, 524.2860).

**Anthriscifolrine** D (**7)**: white, amorphous powder; $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
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                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$${[{\rm{\alpha }}]}_{{\rm{D}}}^{20}$$\end{document}$ −12.8 (*c* 0.50, CHCl~3~); IR (KBr) *v* ~max~: 3461, 2962, 2924, 2873, 2854, 2827, 2752, 1757, 1742, 1647, 1456, 1368, 1245, 1227, 1103, 1088, 1043, 958, 926, 761, 742; ^1^H and ^13^C NMR data see Table [3](#Tab3){ref-type="table"}; HR--ESI--MS at *m/z* 522.2702 \[M + H\]^+^ (calcd. for C~27~H~40~NO~9~, 522.2703).

**Anthriscifolrine** E (**8)**: white, amorphous powder; $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
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                \begin{document}$${[{\rm{\alpha }}]}_{{\rm{D}}}^{20}$$\end{document}$ −10.7 (*c* 0.30, CHCl~3~); IR (KBr) *v* ~max~: 3447, 2962, 2926, 2885, 2857, 2818, 2746, 1741, 1717, 1463, 1370, 1265, 1230, 1092, 1075, 1052, 953, 913, 756, 729, 710; ^1^H and ^13^C NMR data see Table [3](#Tab3){ref-type="table"}; HR--ESI--MS at *m/z* 494.2752 \[M + H\]^+^ (calcd. for C~26~H~40~NO~8~, 494.2754).

**Anthriscifolrine** F (**9)**: white, amorphous powder; $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
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                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$${[{\rm{\alpha }}]}_{{\rm{D}}}^{20}$$\end{document}$ −15.0 (*c* 0.30, CHCl~3~); IR (KBr) *v* ~max~: 3528, 3382, 2958, 2925, 2889, 2855, 2817, 1742, 1666, 1464, 1388, 1371, 1327, 1239, 1158, 1132, 1045, 1103, 1087, 1072, 1051, 1001, 970, 955, 921, 781, 757, 731; ^1^H and ^13^C NMR data see Table [3](#Tab3){ref-type="table"}; HR--ESI--MS at *m/z* 466.2817 \[M + H\]^+^ (calcd. for C~25~H~40~NO~7~, 466.2805).

Crystal Data of **1**: C~29~H~31~NO~7~, *M*r 505.21, *a* = 12.9571(5) Å, *b* = 20.9703(17) Å, c = 21.7049(12) Å, *V* = 5897.5(6) Å^3^, space group *P*2~1~2~1~2~1~, Z = 8, *D* ~calc~ = 1.204 Mg/m^3^, λ = 0.71073 Å, *μ*(Moka) = 0.086 mm^−1^, *F*(000) = 2272.0, and *T* = 293.15 K; Data were collected using an orthorhombic of size 0.4 × 0.1 × 0.05 mm^3^ in the range −15 ≤ *h* ≤ 16, −24 ≤ *k* ≤ 26, −27 ≤ *l* ≤ 16. 21557 reflections measured, 11486 unique reflections *R* ~int~ = 0.0297. Refinement by full--matrix least--squares on *F* ^2^ converged to give final *R* indices *R* ~1~ = 0.0781, *wR* ~2~ = 0.1779 \[I \> 2σ(*I*)\] and *R* ~1~ = 0.1399, *wR* ~2~ = 0.2106 (all data).

Data/restraints/parameters = 11486/1/725, goodness--of--fit on *F* ^2^ = 0.988, largest difference peak and hole are 0.25 and −0.19 e Å^−3^. Crystallographic data for **1** have been deposited with the Cambridge Crystallographic Data Center as supplementary publication number CCDC 1487703. These data can be obtained free of charge via [www.ccdc.cam.ac.uk/deposit](http://www.ccdc.cam.ac.uk/deposit) (or from the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; fax: + 44 1223336033; deposit\@ccdc.cam.ac.uk).

Crystal Data of **11**: C~29~H~31~NO~7~, *M*r 505.21, *a* = 13.1758(7) Å, *b* = 18.3883(9) Å, c = 21.9022(13) Å, *V* = 5306.5(5) Å^3^, space group *P*2~1~2~1~2~1~, Z = 8, *D* ~calc~ = 1.263 Mg/m^3^, λ = 0.71073 Å, *μ*(Moka) = 0.090 mm^−1^, *F*(000) = 2136.0, and *T* = 293.15 K; Data were collected using an orthorhombic of size 0.4 × 0.08 × 0.08 mm^3^ in the range −16 ≤ *h* ≤ 15, −13 ≤ *k* ≤ 22, −23 ≤ *l* ≤ 27. 17628 reflections measured, 9715 unique reflections *R* ~int~ = 0.0250. Refinement by full--matrix least--squares on *F* ^2^ converged to give final *R* indices *R* ~1~ = 0.0551, *wR* ~2~ = 0.1345 \[I \> 2σ(*I*)\] and *R* ~1~ = 0.07969, *wR* ~2~ = 0.1498 (all data).

Data/restraints/parameters = 9715/0/687, goodness--of--fit on *F* ^2^ = 0.999, largest difference peak and hole are 0.36 and −0.14 e Å^−3^. Crystallographic data for **11** have been deposited with the Cambridge Crystallographic Data Center as supplementary publication number CCDC 1487702. These data can be obtained free of charge via [www.ccdc.cam.ac.uk/deposit](http://www.ccdc.cam.ac.uk/deposit) (or from the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; fax: + 44 1223336033; deposit\@ccdc.cam.ac.u k).

Cell Culture and Cytotoxicity Assay {#Sec9}
-----------------------------------

The cytotoxicity of the compounds against cultured human tumor cell lines such as MCF--7, HepG2 and H460 cell lines was evaluated by the MTT method as described in our previous paper^[@CR14]^. Cells treated with DMSO (0.1% *v*/*v*) were used as negative controls, whereas adriamycin (≥98%; Sigma Chemical Co., Ltd., Shanghai, China) was used as the positive control.
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